Mushroom Biotransformation: New Compounds from Fermentation

Fermented Mushrooms

30 new compounds

When lactic acid bacteria fermented shiitake, mass spectrometry found 30 entirely new phenolic compounds that didn't exist in the fresh mushroom before fermentation.

Ayar-Sumer et al., Foods, 2024

40–180%

phenolic increase when mushroom mycelium grows through cereal grain substrates

2 distinct

immune activation profiles from turkey tail mycelium vs. its fermented substrate

3 mechanisms

by which fermentation creates new mushroom bioactives

Ayar-Sumer et al., Foods, 2024

View as image ↗

When Ayar-Sumer and colleagues fermented shiitake mushrooms with lactic acid bacteria in 2024, they analyzed the result with mass spectrometry. Thirty entirely new phenolic compounds appeared in the fermented extract. These were compounds absent from the fresh starting material, absent because they hadn't existed before the fermentation ran.^[1] The fermentation hadn't just concentrated or released what was already there. It had generated compounds that didn't previously exist. This is what researchers call mushroom biotransformation.

The term matters because it describes something genuinely different from what most fermented mushroom marketing implies. Bioavailability enhancement means making existing compounds easier to absorb. Biotransformation, in the fermentation context, means creating new compounds through microbial metabolism: a chemical transformation of the starting material, not just better extraction of it. Both happen during fermentation, but they are not the same process, and conflating them means missing the more interesting half of the story. For context on how other mushroom processing methods affect bioactives, see mushroom extraction methods explained.

Liberation vs. Creation: The Distinction That Changes How You Read a Supplement Label

Supplement brands frequently describe fermented mushrooms as "predigested" or "more bioavailable." This language captures one real phenomenon while leaving the more surprising one unnamed.

Mushroom cell walls are built from chitin, a tough structural material that the human gut cannot efficiently break down. Many biologically active mushroom compounds, including phenolic antioxidants and some beta-glucans studied for immune effects, are physically bound within this matrix. When fermentation microorganisms secrete enzymes that attack the cell wall, those bound compounds are freed into a form the digestive system can process. This is bioavailability enhancement: more of what was already there becomes accessible.

Biotransformation is different. When Ayar-Sumer's team ran the fermented shiitake through mass spectrometry and found 30 new phenolics, those compounds weren't hiding in the cell wall waiting to be unlocked.^[1] They were built during fermentation itself, as microbial metabolism took the mushroom's chemistry as raw material and converted it into something new. The distinction matters practically: extraction methods and fine milling can achieve liberation of existing compounds. Only fermentation can achieve biotransformation.

Ulziijargal and colleagues demonstrated both effects together in a 2012 study of fermented king oyster mushroom. The fermented extract showed significantly higher antioxidant activity and stronger macrophage stimulation than the unfermented extract, with beta-glucan content preserved through the fermentation process.^[6] The study couldn't separately attribute how much of the enhanced activity came from better compound release versus new compound creation, but the Ayar-Sumer 2024 data, published twelve years later with more precise analytical tools, makes clear that both mechanisms operate in parallel.

The 30 New Compounds: Biotransformation Documented by Mass Spectrometry

Ayar-Sumer's study put shiitake (Lentinula edodes) and saffron milk cap mushrooms through lactic acid bacteria fermentation and tracked phenolic compounds at baseline and after fermentation using mass spectrometry, an analytical technique that identifies individual molecules by their mass-to-charge ratio.

After 24 hours of fermentation, free phenolic content had increased substantially. But the data showed something beyond a simple quantity increase: 30 compounds appeared in the post-fermentation sample with no corresponding signal in the pre-fermentation analysis. These were new molecules, not amplified versions of existing ones.^[1]

Three mechanisms drive this kind of biotransformation:

1. Enzymatic hydrolysis. Lactic acid bacteria secrete enzymes including ferulic acid esterases that cleave the structural bonds holding phenolic compounds in the cell wall matrix. The freed phenolics enter the extractable fraction, increasing measured content.

2. Metabolic conversion. LAB take phenolic acids from the mushroom and convert them into chemically related but structurally distinct compounds as part of their normal metabolism. Caffeic acid, for example, can be converted into hydroxytyrosol; chlorogenic acids can be split into quinic acid and caffeic acid. The resulting molecules have different biological activity profiles than the originals.

3. Microbial synthesis. The fermenting bacteria produce their own secondary metabolites, including certain organic acids, enzymes, and B vitamins, that weren't part of the mushroom's chemistry at all. These become part of the finished fermented product.

The shiitake-specific context here is worth noting. The native bioactive compounds in fresh shiitake, including lentinan, eritadenine, and ergothioneine, serve as some of the starting material that LAB metabolism works on. For more on what those compounds do before fermentation changes them, see shiitake bioactive compounds: lentinan, eritadenine, and beyond.

How Mushroom Mycelium Transforms Grain: The 40–180% Phenolic Finding

Xu and colleagues published a 2018 study that approached biotransformation from an angle that has significant implications for supplement labeling.

Instead of asking what fermentation does to mushroom compounds, they asked what mushroom mycelium does to the grain substrate it grows through. The researchers used solid-state fermentation conditions to grow oyster mushroom, shiitake, and lion's mane mycelium on cereal grains: oats, barley, and wheat. They then measured total phenolic content and antioxidant activity in the fermented grain matrix, compared to unfermented control grain.

Total phenolic content increased by 40 to 180 percent across the tested grain-mushroom combinations. DPPH antioxidant activity increased by 50 to 200 percent.^[2]

These phenolics didn't come from the mushroom migrating into the grain. They were generated by mycelial enzyme activity on the grain matrix itself. Mushroom mycelium secretes laccases, peroxidases, and ferulic acid esterases as it colonizes a substrate. These enzymes break down the ferulic acid esters that are structurally incorporated into cereal grain cell walls, freeing phenolic acids and converting some of them into new hydroxycinnamic acid derivatives through further enzymatic action.

The mycelium is transforming the grain, not just living in it.

This has a direct practical implication for the "myceliated grain" supplements that have been the subject of industry debate. Products where mushroom mycelium is grown on oats or brown rice and the whole fermented matrix is then dried and powdered contain both the mycelium's own bioactive compounds and the new phenolics generated through this substrate transformation. They are neither pure mushroom extract nor plain grain. The biotransformation creates a third category: a chemically transformed food matrix with its own distinct compound profile. Whether that profile is preferable to a hot water or alcohol extract of the fruiting body depends on which compounds you're measuring. The transformation itself is real and documentable.

One Mushroom, Two Immune Targets: What the Turkey Tail Data Reveals

Benson and colleagues published a 2019 in vitro study that provides perhaps the clearest single illustration of why fermented substrate is not the same as concentrated mushroom.

They grew turkey tail (Trametes versicolor) mycelium through a solid grain substrate under SSF conditions. After fermentation, they separated the two fractions: the mycelium itself and the spent fermented substrate, the colonized grain the mycelium had transformed. Each fraction was then tested independently for immune activation in cell culture.

The mycelium fraction activated natural killer cells, which are part of the body's rapid-response immune layer. These cells detect and destroy virus-infected or abnormal cells without needing prior instruction from other immune components.^[4]

The fermented substrate activated dendritic cells: a different immune cell type that acts as a bridge between early immune responses and longer-term adaptive immunity. Dendritic cells process threats and present information about them to T cells, coordinating a more targeted response over time.

Two distinct immune mechanisms from two fractions of the same fermented product. Neither fraction alone captured both effects. A product using only the mycelium would miss the substrate's dendritic cell activation. A product using only the substrate would miss the mycelium's NK cell activation.

For more on the specific compounds native to turkey tail before fermentation transforms the substrate, see turkey tail bioactive compounds: PSK, PSP, and beta-glucans.

The Three-Way Test: Why Fermented P. eryngii Beat Both Fruiting Body and Mycelium

Liang and colleagues ran a direct comparison in 2013 that puts the biotransformation claim to a practical test with measurable outcomes.

They took king oyster mushroom (Pleurotus eryngii) and produced three preparations: the whole fruiting body, mycelium grown in liquid culture, and a fermented product. Then they measured ergothioneine content, total phenolics, and DPPH antioxidant activity across all three.

The fermented product ranked highest on all three measures. It had more ergothioneine than the fruiting body. Its antioxidant activity exceeded both the fruiting body and the mycelium.^[3]

Ergothioneine is a dietary compound the human body cannot produce itself, found in relatively high concentrations in mushrooms compared to most other foods. Its appearance at elevated levels in the fermented product over the fruiting body is a concrete, measurable example of fermentation genuinely increasing the density of a nutritionally relevant compound, not merely making the same content easier to absorb.

The honest counterpoint from the same research space: Berger and colleagues published a 2022 systematic review of the metabolite differences between mushroom mycelium and fruiting bodies across species. Their conclusion was that neither form is universally superior. Mycelium contains higher concentrations of certain enzymes and volatile compounds in some species; fruiting bodies retain more beta-glucans and ergothioneine in others.^[5] Adding fermentation to the comparison introduces a third set of variables, and Liang 2013's result with P. eryngii doesn't automatically generalize to every species, fermentation method, or processing duration.

The data points in a consistent direction: well-executed fermentation can produce a final product that outperforms the unfermented source on specific bioactive measures. But "fermented" alone is not a quality guarantee, and the underlying conditions that produce the enhancement matter.

What the Research Actually Tells You When a Label Says "Fermented"

The practical question most people reach is whether fermented mushroom products are worth seeking out and how to evaluate them honestly.

The research in this cluster points toward a few defensible conclusions.

Fermentation can genuinely create new bioactive compounds not present in fresh or dried mushrooms. Ayar-Sumer 2024's mass spectrometry data is direct analytical evidence of this, not a mechanistic inference.^[1] The Benson 2019 dual immune-target finding reinforces it with a functional readout: the fermented substrate did things the mycelium alone did not.^[4]

The specific compounds that form depend on the fermentation conditions. Which microorganism is used (lactic acid bacteria, a SCOBY, Aspergillus, mushroom mycelium itself), what the substrate is, fermentation duration, temperature, and pH all shape the output profile. A product labeled "fermented" without specifying these parameters could range from substantially transformed to minimally changed from the original mushroom material. Beverage formats like reishi kombucha add another layer of complexity, since SCOBY fermentation dynamics differ from LAB; the published evidence on mushroom-enhanced beverages is examined in fermented mushroom beverages: kombucha, beer, and beyond.

The Berger 2022 metabolomics review established that mycelium and fruiting bodies have distinct profiles; neither form is universally superior.^[5] Fermented mycelium, fermented fruiting body extract, and fermented grain substrate are three different things with three different chemical profiles. The label alone doesn't specify which.

For readers tracking the beta-glucan absorption question, the fermentation cell-wall breakdown process is directly relevant: see beta-glucan bioavailability: can your gut actually absorb them?. For the companion article on which mushroom species and fermentation formats show the clearest evidence of enhanced activity overall, see fermented mushrooms: do they have enhanced bioactivity?. The specific trade-offs between solid-state and liquid fermentation methods are covered in solid-state vs. liquid fermentation for mushroom products, and the deeper enzyme chemistry of SSF compound creation is in solid-state fermentation and mushroom bioactivity: how processing creates new compounds.

The Bottom Line

Mushroom biotransformation is the creation of new bioactive compounds during fermentation, as distinct from the liberation of existing bound compounds through cell wall breakdown. Both processes happen during fermentation, but only biotransformation produces chemistry that didn't exist in the original mushroom. Ayar-Sumer 2024 documented 30 new phenolics in fermented shiitake via mass spectrometry. Xu 2018 showed mushroom mycelium transforming grain substrate phenolics by 40–180%. Benson 2019 found fermented turkey tail substrate activating different immune cells than the mycelium itself. The evidence consistently shows that well-executed fermentation creates a chemically distinct product from its components. But outcomes vary significantly with fermentation conditions, and "fermented" alone is not a reliable quality indicator.

Frequently Asked Questions

What is biotransformation in mushroom fermentation?

Mushroom biotransformation is the creation of entirely new chemical compounds during fermentation, not just the release of compounds already present in the mushroom. During fermentation, microorganisms secrete enzymes that break down the mushroom's cell structures and metabolize existing compounds into new secondary metabolites. Ayar-Sumer et al. (2024) demonstrated this directly by identifying 30 new phenolic compounds in fermented shiitake using mass spectrometry. These compounds had no signal in the pre-fermentation analysis, distinguishing biotransformation from simple bioavailability enhancement.

How does fermentation create new bioactive compounds from mushrooms?

Fermentation creates new mushroom compounds through three mechanisms. First, microbial enzymes break the structural bonds holding phenolic compounds inside the cell wall matrix, freeing them. Second, the fermenting microorganism takes existing mushroom phenolic acids and converts them into chemically related but structurally distinct derivative compounds through its own metabolic activity. Third, the microorganism contributes its own secondary metabolites, including organic acids, enzymes, and B vitamins, that weren't part of the mushroom's chemistry before fermentation. The Ayar-Sumer 2024 study showed all three in operation across a 24-hour lactic acid bacteria fermentation of shiitake.

What enzymes are involved in mushroom biotransformation?

The key enzymes include cellulases and laccases (which break down the chitin and glucan cell wall structure), ferulic acid esterases (which cleave phenolic acids from grain and mushroom fiber), and peroxidases (which participate in phenolic oxidation and coupling). In lactic acid bacteria fermentation, additional enzymes like tannase and phenolic acid decarboxylases convert phenolic acids into new derivative forms. Xu et al. (2018) showed that mushroom mycelial laccases and ferulic acid esterases are active enough on grain substrates to increase phenolic content by 40–180% in the fermented grain matrix alone.

Can fermentation create compounds not found in fresh mushrooms?

Yes, and this has been directly documented analytically. Ayar-Sumer et al. (2024, Foods) used mass spectrometry to identify 30 phenolic compounds in lactic acid bacteria-fermented shiitake that were completely absent from the unfermented mushroom before fermentation. They were not found at lower concentrations but were entirely absent. Benson et al. (2019) found that the fermented grain substrate from turkey tail SSF activated dendritic cells in a way the turkey tail mycelium itself did not, indicating functional differences attributable to newly created compounds in the substrate fraction.

What is lactic acid fermentation of mushrooms?

Lactic acid fermentation of mushrooms involves inoculating a mushroom substrate with lactic acid bacteria and allowing fermentation to proceed over 24–72 hours at controlled temperature and pH. LAB metabolize sugars in the substrate and produce lactic acid as a primary byproduct, lowering pH. In the process, they secrete enzymes that break down the mushroom cell wall and convert phenolic compounds into new derivatives. Ayar-Sumer et al. (2024) applied this method to shiitake and saffron milk cap mushrooms, finding significant increases in free phenolic content and the appearance of 30 new phenolic compounds absent from fresh mushroom.

Sources & References

1. 1. Source details for this reference are not yet available.
2. 2. Source details for this reference are not yet available.
3. 3. Source details for this reference are not yet available.
4. 4. Source details for this reference are not yet available.
5. 5. Source details for this reference are not yet available.
6. 6. Source details for this reference are not yet available.